STOCK TITAN

Koninklijke Phil Stock Price, News & Analysis

PHG NYSE

Welcome to our dedicated page for Koninklijke Phil news (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Phil stock.

Koninklijke Philips N.V. (NYSE: PHG) is a global leader in health technology focused on improving lives through meaningful innovation. This news hub provides investors and healthcare professionals with centralized access to official press releases and verified updates about Philips' advancements in diagnostic imaging, connected care systems, and personal health solutions.

Discover timely information on product launches, regulatory milestones, and strategic partnerships that shape Philips' position in the healthcare sector. Our curated collection includes earnings reports, technology innovations, and market expansion announcements – all essential for understanding the company's trajectory in medical equipment and digital health solutions.

Key updates cover developments in AI-driven diagnostic tools, telehealth platforms, and sustainable healthcare initiatives. Bookmark this page to stay informed about Philips' progress in addressing critical challenges across radiology, cardiology, and home-based patient care through its integrated health technology ecosystem.

Rhea-AI Summary

Royal Philips (NYSE: PHG) announced the launch of its new Spectral Computed Tomography (CT) 7500, enhancing precision diagnostics across various patient demographics, including cardiac, pediatric, and bariatric populations. This intelligent system provides high-quality spectral images at standard dose levels, significantly reducing time to diagnosis by 34%, along with a 25% decrease in repeat scans and a 30% reduction in follow-ups. The CT 7500 aims to mitigate the estimated $12 billion annual costs associated with misdiagnosis and inefficient imaging practices.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
none
-
Rhea-AI Summary

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG) has announced the European launch of innovative health technology solutions during the EuroPCR 2021 event (May 18-20). The portfolio includes the Interventional Applications Platform – IntraSight Mobile, facilitating coronary disease therapy, and the OmniWire Pressure Guide Wire, the world’s first solid-core pressure wire for coronary interventions, now CE marked. Additionally, the Philips Laser System simplifies coronary and peripheral atherectomy procedures, enhancing clinical efficiency and patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
none
-
Rhea-AI Summary

Royal Philips (NYSE: PHG) announced the integration of its Interventional Hemodynamic System with the Patient Monitor IntelliVue X3 to enhance clinical decision-making and patient monitoring during interventional procedures. This integration allows for continuous monitoring of vital signs and advanced hemodynamic measurements, improving workflow and patient safety. The solution will be showcased at ACC.21 from May 15-17, 2021. While the system is available globally, it is currently not for sale in the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
none
Rhea-AI Summary

On May 12, 2021, Royal Philips (PHG) commemorated its 130th anniversary, reflecting on a legacy of innovation aimed at enhancing healthcare. Philips aims to impact 2.5 billion lives annually by 2030 through robust R&D investments of EUR 1.8 billion, with a portfolio of around 59,000 patents. The company has pioneered various medical imaging technologies since World War I and continues to develop AI-driven healthcare solutions. Recent innovations include the AI Workflow Suite and the Azurion Therapy System, emphasizing partnerships with leading healthcare institutions to advance diagnostic and treatment capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.64%
Tags
none
-
Rhea-AI Summary

Royal Philips (NYSE: PHG) has donated ultrasound imaging solutions to MedShare, aiding safety net clinics like Axis Community Health in California. This initiative supports the Safe Birthing Initiative, addressing birth equity challenges and improving prenatal care for underserved communities. The Bay Area faces stark racial disparities in maternal care, with African American women significantly more affected. The donation aims to enhance healthcare access, enabling better outcomes for mothers and newborns. MedShare works with over 64 clinics, emphasizing the need for quality care resources in low-income areas.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
none
-
Rhea-AI Summary

Royal Philips (NYSE: PHG) held its 2021 Annual General Meeting of Shareholders on May 6, 2021. During this meeting, Mr. Marnix van Ginneken was re-appointed to the Board of Management, while Mrs. Chua Sock Koong and Mrs. Indra Nooyi were appointed to the Supervisory Board. Additionally, the proposal to distribute a dividend of EUR 0.85 per share for the fiscal year 2020 was approved. Philips reported sales of EUR 17.3 billion in 2020 and continues to focus on enhancing health technology solutions globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
none
Rhea-AI Summary

On May 5, 2021, Royal Philips released the Future Health Index 2021 report, representing the largest global survey of healthcare leaders from 14 countries. The survey reveals that 64% prioritize telehealth investments amid the ongoing pandemic, with a projected increase in artificial intelligence investments (from 36% to 74%) in three years. The report emphasizes sustainability, with 58% of leaders planning to prioritize environmental practices. Despite crises, 86% of leaders express optimism regarding healthcare resilience.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.17%
Tags
none
-
Rhea-AI Summary

Connect America has announced its acquisition of Philips' Aging and Caregiving (ACG) business, which includes the Lifeline Personal Emergency Response System. This strategic move aims to enhance services for North American subscribers by integrating ACG's digital caregiving solutions into Connect America's offerings. The deal is expected to close soon, pending regulatory approvals, with Philips retaining an equity stake in Connect America. Executives from both companies emphasized the synergy and shared commitment to improving care for aging individuals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.17%
Tags
-
Rhea-AI Summary

On May 4, 2021, Philips Foundation published its 2020 Annual Report, showcasing over 75 successful projects that provided healthcare access to 7.5 million underserved individuals worldwide. The initiatives encompassed various regions, including Africa and China, primarily addressing COVID-19 impacts. Notable projects included donations of medical equipment in Wuhan, AI software for South African hospitals, and mobile ICUs for Italy and Lebanon. The Foundation aims to foster partnerships with social entrepreneurs to develop sustainable healthcare models, continuing its mission to mitigate healthcare inequality globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.78%
Tags
none
Rhea-AI Summary

In Q1 2021, Royal Philips reported group sales of EUR 3.8 billion, reflecting a 9% comparable sales growth despite challenges related to COVID-19. The Domestic Appliances business has been classified as a discontinued operation following its sale to Hillhouse Capital. Income from continuing operations showed a loss of EUR 34 million, impacted by a EUR 250 million provision for quality issues in sleep and respiratory care products. Adjusted EBITA rose to EUR 362 million, while operating cash flow improved to EUR 321 million, highlighting strong performance in Diagnosis & Treatment and Personal Health segments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.8%
Tags
none

FAQ

What is the current stock price of Koninklijke Phil (PHG)?

The current stock price of Koninklijke Phil (PHG) is $22.29 as of June 20, 2025.

What is the market cap of Koninklijke Phil (PHG)?

The market cap of Koninklijke Phil (PHG) is approximately 21.9B.
Koninklijke Phil

NYSE:PHG

PHG Rankings

PHG Stock Data

21.85B
925.01M
6.49%
0.26%
Medical Devices
Healthcare
Link
Netherlands
Amsterdam